Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Newron PharmaceuticalsAraviveMonopar TherapeuticsPhaseBio PharmaceuticalsIDEAYA Biosciences
SymbolOTCMKTS:NWPHFNASDAQ:ARAVNASDAQ:MNPRNASDAQ:PHASNASDAQ:IDYA
Price Information
Current Price$7.50$6.16$6.72$3.28$4.49
52 Week RangeN/ABuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$26.00$42.00$15.33$17.29
% Upside from Price TargetN/A322.08% upside525.00% upside367.48% upside284.98% upside
Trade Information
Market Cap$133.88 million$92.50 million$72.88 million$90.37 million$88.29 million
Beta0.042.4N/A2.08N/A
Average Volume10149,74216,517406,54950,381
Sales & Book Value
Annual Revenue$7.88 million$4.75 millionN/A$2.36 millionN/A
Price / Sales16.9919.47N/A40.00N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.63 per share$4.71 per share$1.19 per share$2.09 per share$4.94 per share
Price / Book2.071.31N/A1.57N/A
Profitability
Net Income$-22,640,000.00$-18,220,000.00$-4,220,000.00$-39,250,000.00$-41,970,000.00
EPS($1.27)($1.57)($0.45)($1.43)($3.36)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio15.63N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-1,662.30%N/A
Return on Equity (ROE)N/A-32.47%-60.03%-61.21%N/A
Return on Assets (ROA)N/A-25.70%-55.57%-48.67%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.11%N/A0.23%0.06%
Current RatioN/A13.73%18.27%9.30%14.65%
Quick RatioN/A13.73%18.27%9.30%14.65%
Ownership Information
Institutional Ownership PercentageN/A42.87%0.25%67.69%51.16%
Insider Ownership PercentageN/A39.80%N/A17.00%N/A
Miscellaneous
Employees241442256
Shares Outstanding17.85 million15.02 million10.62 million28.78 million20.34 million
Next Earnings Date6/4/2020 (Estimated)5/13/2020 (Estimated)6/26/2020 (Estimated)5/14/2020 (Estimated)6/23/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel